Cytoplasmic HuR expression correlates with P-gp, HER-2 positivity, and poor outcome in breast cancer.
about
RNA epigeneticsCurrent Evidence and Future Perspectives on HuR and Breast Cancer Development, Prognosis, and TreatmentMultiple functions of the RNA-binding protein HuR in cancer progression, treatment responses and prognosisLoss of constitutive ABCB1 expression in breast cancer associated with worse prognosisRegulation of the mRNA half-life in breast cancerTargeting the mRNA-binding protein HuR impairs malignant characteristics of pancreatic ductal adenocarcinoma cellsPost-transcriptional up-regulation of PDGF-C by HuR in advanced and stressed breast cancer.Identification and validation of novel small molecule disruptors of HuR-mRNA interaction.MicroRNA-16 modulates HuR regulation of cyclin E1 in breast cancer cellsIdentification of Small-Molecule Inhibitors of the HuR/RNA Interaction Using a Fluorescence Polarization Screening Assay Followed by NMR ValidationInfluence of MDR1 methylation on the curative effect of interventional embolism chemotherapy for cervical cancerAutotaxin Expression Is Regulated at the Post-transcriptional Level by the RNA-binding Proteins HuR and AUF1.Can we observe changes in mRNA "state"? Overview of methods to study mRNA interactions with regulatory proteins relevant in cancer related processes.Clinical significance of HuR expression in human malignancy.Elevated Hu-Antigen Receptor (HuR) Expression is Associated with Tumor Aggressiveness and Poor Prognosis but not with COX-2 Expression in Invasive Breast Carcinoma Patients.HuR mediated post-transcriptional regulation as a new potential adjuvant therapeutic target in chemotherapy for pancreatic cancer.Dysregulation of TTP and HuR plays an important role in cancers.Post-transcriptional regulation of cytokine and growth factor signaling in cancer.Clinical Significance of Hu-Antigen Receptor (HuR) and Cyclooxygenase-2 (COX-2) Expression in Human Malignant and Benign Thyroid Lesions.Modulation of the mRNA-binding protein HuR as a novel reversal mechanism of epirubicin-triggered multidrug resistance in colorectal cancer cellsPredictive and prognostic significance of cytoplasmic expression of ELAV-like protein HuR in invasive breast cancer treated with neoadjuvant chemotherapy.Cytoplasmic expression of the ELAV-like protein HuR as a potential prognostic marker in esophageal squamous cell carcinoma.Ancient and modern: hints of a core post-transcriptional network driving chemotherapy resistance in ovarian cancer.PD-1/PD-L1 interaction up-regulates MDR1/P-gp expression in breast cancer cells via PI3K/AKT and MAPK/ERK pathways.Coming of Age for Autotaxin and Lysophosphatidate Signaling: Clinical Applications for Preventing, Detecting and Targeting Tumor-Promoting Inflammation.BAG3 regulates stability of IL-8 mRNA via interplay between HuR and miR-4312 in PDACs
P2860
Q26851610-923F6872-7DFD-4F9D-904D-6AD257E6B49EQ28075325-202338EA-667D-42E2-A1F9-07F22A7A0B0AQ28290458-0A203303-E235-4F83-9593-91409AD3C5F5Q33821114-A8C45659-0A05-4ED5-A6C8-4F547B02A687Q34023658-60572B69-E858-4A7E-A86B-D24E1C8420DEQ34491276-1F32878C-BD7E-462A-A18C-E686182D9E97Q34685349-123602DB-A8F6-40CC-918F-2230B5CB0A3DQ35573530-F7034033-4A7E-4AB1-8B39-8F001D40C74BQ35585464-A732E42F-CCD8-4A84-94B7-3B9C85A838C9Q35781852-5073265B-F666-450C-9CBC-5AAE466E1DC7Q35940551-A95350A0-6441-44F6-A1E6-70E587EA593EQ36175446-CE4FA52A-9B96-4595-B60F-6C67A01FA7D2Q36431066-5C7609B3-0BE1-42F3-9EAB-3E178B67C7DFQ38238932-EF4903D2-964F-4C59-9CA3-0C09B6DCD91FQ38624619-4C8AC071-0579-4BC1-B088-828BB69D457CQ38811283-4B9B751E-1673-44A9-BDC2-9871B00DD0E7Q38958552-7B905AAC-5506-4C77-82F2-32B0F600081EQ39036700-03BD4024-B861-49E4-947E-F2FC2024AE69Q40396217-C6AD50BD-402B-4EDB-B886-FB7FD8E589B6Q42368968-BC8140AE-A5C9-47F2-B314-FDEDE742BD68Q45929654-1CF547AC-EF1E-4191-8301-FA2027BD37B9Q46930809-11E70165-1FE5-4428-99B4-F5AE3D499823Q47200415-AEAFF274-2516-40FD-B58B-3F0B38FBF5CCQ47289144-E2B7408F-532F-4AFC-A9D5-929CA295CE73Q52689639-CAD6A474-016A-4AEA-8AE9-D0B7A9806494Q58699680-64A21F64-F97F-42CF-A2FF-40F2E3AC1D36
P2860
Cytoplasmic HuR expression correlates with P-gp, HER-2 positivity, and poor outcome in breast cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Cytoplasmic HuR expression cor ...... poor outcome in breast cancer.
@en
Cytoplasmic HuR expression cor ...... poor outcome in breast cancer.
@nl
type
label
Cytoplasmic HuR expression cor ...... poor outcome in breast cancer.
@en
Cytoplasmic HuR expression cor ...... poor outcome in breast cancer.
@nl
prefLabel
Cytoplasmic HuR expression cor ...... poor outcome in breast cancer.
@en
Cytoplasmic HuR expression cor ...... poor outcome in breast cancer.
@nl
P2093
P2860
P1433
P1476
Cytoplasmic HuR expression cor ...... poor outcome in breast cancer.
@en
P2093
Baocheng Wang
Chen Zhong
Cong Zhang
Jingwang Bi
Xiuju Liang
Zhongpeng Zhu
P2860
P2888
P304
P356
10.1007/S13277-013-0774-3
P577
2013-04-19T00:00:00Z